Dynamk Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 5
- Investments
- 11
- Portfolio
- 10
- Exits
- 1
Dynamk Capital General Information
Description
Dynamk Capital is a growth equity and venture capital firm investing in life science companies. Dynamk's investment strategy is centered on Life Science Industrials: companies developing technologies, tools, and services that enable the full biopharma continuum across discovery, development, and manufacturing of therapeutics. Dynamk is headquartered in New York City.
Contact Information
Website
www.dynamk.vc
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 30 Wall Street
- 12th Floor
- New York, NY 10005
- United States
Dynamk Capital Investments (11)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Xcell Biosciences | 19-Jan-2022 | Later Stage VC | 000.00 | Discovery Tools (Healthcare) | Generating Revenue | |
000.000 | 31-Dec-2021 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
0000 000 | 29-Dec-2021 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | 0000000 000000 00.0 |
000000 | 19-Nov-2021 | 00000 00000 | 00.00 | Biotechnology | Generating Revenue | 00000000 0000000 |
000000000000 | 22-Sep-2021 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | |
0000000000 0000000 | 22-Jun-2021 | 00000 00000 | 00.000 | Diagnostic Equipment | Generating Revenue | 0000000 000000 00.0 |
0000000 0000000000 | 17-Jun-2021 | 00000 00000 | 00.00 | Biotechnology | Generating Revenue | 00000000 0000 |
00000 0000000000 | 01-Oct-2020 | 0000 00000 | 00.000 | Other Pharmaceuticals and Biotechnology | Generating Revenue | 0000000 000000 00.0 |
CellFE | 31-Mar-2020 | Seed Round | 00.00 | Other Healthcare Technology Systems | Startup | 00000000 0000000 |
RoosterBio | 10-Sep-2019 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue | 00000000 0000000 |
Dynamk Capital Exits (1)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
000000000 000000 | 10-Oct-2019 | 000000000000000000 |
Dynamk Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialDynamk Capital Team (6)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Daniella Kranjac | Co-Founding Partner & Managing Director | 0 | 0 | 0 | New York, NY |
Gustavo Mahler Ph.D | Managing Partner | 0 | 0 | 0 | New York, NY |
Mario Kranjac JD | Co-Founding Partner & General Counsel | 0 | New York, NY | ||
Reinhard Vogt | Venture Partner | 0 | 0 | 0 | New York, NY |
Sebastien Latapie | Principal | New York, NY |
Dynamk Capital Co-Investors (34)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ARCH Venture Partners | 1 | ||||
Charles River Laboratories | 0 | ||||
GRA Venture Fund | 0 | 0 | |||
Madrona Venture Group | 0 | ||||
Vanedge Capital | 0 | 0 |